+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radiation Toxicity Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Radiation Toxicity Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Radiation Toxicity Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 180 Pages
  • March 2025
  • Region: Global
  • TechSci Research
  • ID: 5900375
Free Webex Call
10% Free customization
Description Jump to:
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Radiation Toxicity Treatment Market was valued at USD 2.48 Billion in 2024, and is expected to reach USD 3.41 Billion by 2030, rising at a CAGR of 5.40%. The Global Radiation Toxicity Treatment Market has witnessed significant growth and evolution in recent years, driven by the increasing incidence of cancer and the expanding use of radiation therapy in cancer treatment. Radiation therapy, while a crucial tool in oncology, can lead to radiation toxicity, which often necessitates specialized treatments and management strategies. This market encompasses a wide range of products and services aimed at mitigating and treating the adverse effects of radiation therapy, making it an essential component of modern cancer care.

The primary drivers of this market's growth is the rising global cancer burden. As cancer incidence continues to rise worldwide, the number of patients undergoing radiation therapy has increased substantially. However, radiation therapy is not without its side effects, and radiation toxicity, including skin reactions, gastrointestinal issues, and organ damage, is a common concern.

This has spurred the demand for radiation toxicity treatment options, including pharmaceuticals, medical devices, and supportive care services. Pharmaceuticals form a crucial segment of the radiation toxicity treatment market, with drugs and medications developed to manage and alleviate the symptoms of radiation toxicity. These pharmaceuticals include anti-inflammatory agents, growth factors, and radioprotective drugs. Additionally, advancements in targeted therapies and immunomodulators hold promise for improving the effectiveness of radiation therapy while reducing associated toxicities.

Key Market Drivers

Increasing Cancer Prevalence

The escalating global incidence of cancer significantly propels the growth of the Radiation Toxicity Treatment Market. This surge in cancer cases leads to increased utilization of radiation therapy, consequently amplifying the demand for treatments addressing radiation-induced toxicities. Recent studies indicate a substantial rise in cancer cases worldwide. For instance, projections suggest in 2022, approximately 20 million new cancer cases were reported globally, resulting in nearly 10 million deaths. Demographic projections suggest that the annual incidence of cancer will rise to 35 million by 2050, representing a 77% increase from 2022 figures. This surge is particularly pronounced in low- and middle-income countries, where healthcare infrastructure may struggle to accommodate the growing burden.

Key Market Challenges

Limited Awareness and Education

One of the primary challenges is the lack of awareness among patients undergoing radiation therapy. For many individuals diagnosed with cancer, the focus understandably shifts to the cancer itself and its treatment. Patients may not be fully informed about the potential side effects of radiation therapy, which can include skin irritation, fatigue, gastrointestinal issues, and damage to healthy tissues. Consequently, they may not actively seek information about radiation toxicity treatment options that could mitigate these adverse effects.

This lack of awareness can lead to suboptimal patient experiences, as individuals may not be proactive in discussing radiation toxicity concerns with their healthcare providers. As a result, they may endure unnecessary discomfort and a reduced quality of life during their treatment journey.

Key Market Trends

Radioprotective Agents and Supportive Care

Radioprotective agents and supportive care have emerged as powerful drivers boosting the Global Radiation Toxicity Treatment Market. These components of radiation toxicity management are gaining increasing attention and significance in the field of cancer care.

Radioprotective agents are pharmaceuticals and treatments developed to shield healthy tissues from the damaging effects of radiation therapy while simultaneously enhancing the tumor's sensitivity to radiation. These agents are designed to minimize radiation-induced toxicities, making radiation therapy safer and more tolerable for patients. The development of radioprotective drugs represents a major breakthrough, as it allows oncologists to optimize radiation treatment protocols without compromising their efficacy. As a result, patients can receive higher doses of radiation to target cancer cells more effectively while experiencing fewer side effects, driving the demand for such agents and boosting the radiation toxicity treatment market.

Key Market Players

  • Amgen Inc.
  • Jubilant Pharma Limited
  • Tanner Pharma Group
  • Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
  • Recipharm AB
  • Mission Pharmacal Company
  • Partner Therapeutics, Inc.
  • Novartis AG
  • Viatris Inc.
  • Coherus Biosciences Inc

Report Scope:

In this report, the Global Radiation Toxicity Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Radiation Toxicity Treatment Market, By Product:

  • Colony Stimulating Factors
  • Potassium Iodide
  • Prussian Blue Diethylenetriamine Pentaacetic Acid
  • Others

Radiation Toxicity Treatment Market, By Indication:

  • Acute Radiation Syndrome
  • Chronic Radiation Syndrome

Radiation Toxicity Treatment Market, By End-user:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Radiation Toxicity Treatment Market, By Radiation Type:

  • Ionizing Radiation
  • Non-ionizing Radiation

Radiation Toxicity Treatment Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Radiation Toxicity Treatment Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Radiation Toxicity Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Colony Stimulating Factors, Potassium Iodide, Prussian Blue Diethylenetriamine Pentaacetic Acid, Others)
5.2.2. By Indication (Acute Radiation Syndrome, Chronic Radiation Syndrome)
5.2.3. By Radiation Type (Ionizing Radiation, Non-ionizing Radiation)
5.2.4. By End-user (Hospitals & Clinics, Ambulatory Care Centers, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Radiation Toxicity Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Indication
6.2.3. By Radiation Type
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Radiation Toxicity Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Indication
6.3.1.2.3. By Radiation Type
6.3.1.2.4. By End User
6.3.2. Canada Radiation Toxicity Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Indication
6.3.2.2.3. By Radiation Type
6.3.2.2.4. By End User
6.3.3. Mexico Radiation Toxicity Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Indication
6.3.3.2.3. By Radiation Type
6.3.3.2.4. By End User
7. Europe Radiation Toxicity Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Indication
7.2.3. By Radiation Type
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Radiation Toxicity Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Indication
7.3.1.2.3. By Radiation Type
7.3.1.2.4. By End User
7.3.2. United Kingdom Radiation Toxicity Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Indication
7.3.2.2.3. By Radiation Type
7.3.2.2.4. By End User
7.3.3. Italy Radiation Toxicity Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Indication
7.3.3.2.3. By Radiation Type
7.3.3.2.4. By End User
7.3.4. France Radiation Toxicity Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Indication
7.3.4.2.3. By Radiation Type
7.3.4.2.4. By End User
7.3.5. Spain Radiation Toxicity Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Indication
7.3.5.2.3. By Radiation Type
7.3.5.2.4. By End User
8. Asia-Pacific Radiation Toxicity Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Indication
8.2.3. By Radiation Type
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Radiation Toxicity Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Indication
8.3.1.2.3. By Radiation Type
8.3.1.2.4. By End User
8.3.2. India Radiation Toxicity Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Indication
8.3.2.2.3. By Radiation Type
8.3.2.2.4. By End User
8.3.3. Japan Radiation Toxicity Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Indication
8.3.3.2.3. By Radiation Type
8.3.3.2.4. By End User
8.3.4. South Korea Radiation Toxicity Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Indication
8.3.4.2.3. By Radiation Type
8.3.4.2.4. By End User
8.3.5. Australia Radiation Toxicity Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Indication
8.3.5.2.3. By Radiation Type
8.3.5.2.4. By End User
9. South America Radiation Toxicity Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Indication
9.2.3. By Radiation Type
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Radiation Toxicity Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Indication
9.3.1.2.3. By Radiation Type
9.3.1.2.4. By End User
9.3.2. Argentina Radiation Toxicity Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Indication
9.3.2.2.3. By Radiation Type
9.3.2.2.4. By End User
9.3.3. Colombia Radiation Toxicity Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Indication
9.3.3.2.3. By Radiation Type
9.3.3.2.4. By End User
10. Middle East and Africa Radiation Toxicity Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Indication
10.2.3. By Radiation Type
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Radiation Toxicity Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Indication
10.3.1.2.3. By Radiation Type
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Radiation Toxicity Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Indication
10.3.2.2.3. By Radiation Type
10.3.2.2.4. By End User
10.3.3. UAE Radiation Toxicity Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Indication
10.3.3.2.3. By Radiation Type
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Radiation Toxicity Treatment Market: SWOT Analysis
14. Competitive Landscape
14.1. Amgen Inc.
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Jubilant Pharma Limited
14.3. Tanner Pharma Group
14.4. Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
14.5. Recipharm AB
14.6. Mission Pharmacal Company
14.7. Partner Therapeutics, Inc.
14.8. Novartis AG
14.9. Viatris Inc.
14.10. Coherus Biosciences Inc.
15. Strategic Recommendations16. About the Publisher & Disclaimer

Companies Mentioned

  • Amgen Inc.
  • Jubilant Pharma Limited
  • Tanner Pharma Group
  • Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
  • Recipharm AB
  • Mission Pharmacal Company
  • Partner Therapeutics, Inc.
  • Novartis AG
  • Viatris Inc.
  • Coherus Biosciences Inc

Table Information

Report AttributeDetails
No. of Pages180
PublishedMarch 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.48 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.41 Billion
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Radiation Toxicity - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Radiation Toxicity - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Anti-Radiation Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Anti-Radiation Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From
Zollinger Ellison Syndrome Market - Product Image

Zollinger Ellison Syndrome Market

  • Report
  • 250 Pages
  • Global
From
Erdheim Chester Disease Market Report 2025 - Product Image

Erdheim Chester Disease Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Anti-Vascular Endothelial Growth Factor Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Image

Anti-Vascular Endothelial Growth Factor Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From

About the Radiation Toxicity Drug Market

The Radiation Toxicity Drug market within the context of Central Nervous System Drugs is a specialized sector of the pharmaceutical industry. It focuses on the development of drugs to treat the side effects of radiation therapy, such as cognitive impairment, fatigue, and nausea. These drugs are designed to reduce the severity of radiation-induced symptoms and improve the quality of life for patients. The Radiation Toxicity Drug market is a rapidly growing sector, as the number of cancer patients receiving radiation therapy continues to increase. This has led to an increased demand for drugs to treat radiation-induced side effects. The Radiation Toxicity Drug market is highly competitive, with many companies developing and marketing drugs to treat radiation-induced side effects. Some of the major players in this market include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.